Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01000623 · ClinicalTrials.gov registry record · NA
Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT01000623: Completed NA study, sponsored by Mayo Clinic.
NCT01000623 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01000623, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
Rationale: Venlafaxine may help relieve hot flashes in women who have had breast cancer. Hypnosis or focused attention may help control hot flashes in postmenopausal women. It is not yet known whether giving venlafaxine together with hypnosis or focused attention is more effective in treating hot flashes. Purpose: This randomized clinical trial is studying venlafaxine together with hypnosis or focused attention in treating patients with hot flashes.
Interventions
- DRUG placebo
- DRUG venlafaxine
- PROCEDURE hypnotherapy
- PROCEDURE mind-body intervention procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2010-01-31 |
| Est. Completion | 2015-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01000623
The ClinicalTrials.gov registry entry for NCT01000623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT01000623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01000623 about?
NCT01000623 is a clinical study titled "Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes". Rationale: Venlafaxine may help relieve hot flashes in women who have had breast cancer. Hypnosis or focused attention may help control hot flashes in postmenopausal women. It is not yet known whether giving venlafaxine together with hypnosis or focused attention is more effective in treating hot fl...
What is the current status of trial NCT01000623?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2010-01-31. Estimated completion is 2015-09-08.
What interventions are being tested in trial NCT01000623?
The interventions under investigation include: placebo (DRUG), venlafaxine (DRUG), hypnotherapy (PROCEDURE), mind-body intervention procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01000623?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.